CGON · CG Oncology, Inc.
AI read · Good for CGON
The AI's read
The higher targets suggest analysts see more room for CG Oncology's shares to rise. RBC's cut to Sector Perform is a caution, but it also raised its target. All 3 firms raised targets, and 2 kept positive ratings, so the changes lean favorable.